Avtal | $24,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Protai
Israel
- Tel Aviv
- 05/01/2022
- Seed
- $8,000,000
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- Industry Biotechnology Research
- Website https://www.protai.bio/
- LinkedIn https://www.linkedin.com/company/protai-bio/about/
Related People
Eran SegerCo Founder
Israel -
Tel Aviv
My passion lays at the intersection of cutting edge technology and innovative biology. Building on over 15 years of experience in various leadership positions in the High-tech & Cyber field together with my knowledge and passion for the computational-bio space, I co-founded Protai a tech driven drug development computational biology startup.
Protai has built an end-to-end AI-based platform that comprehensively maps the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are discovered.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Health Universe | $6,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)